17
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction and hypothesis

          The COVID-19 pandemic and the desire to “flatten the curve” of transmission have significantly affected the way providers care for patients. Female Pelvic Medicine and Reconstructive Surgeons (FPMRS) must provide high quality of care through remote access such as telemedicine. No clear guidelines exist on the use of telemedicine in FPMRS. Using expedited literature review methodology, we provide guidance regarding management of common outpatient urogynecology scenarios during the pandemic.

          Methods

          We grouped FPMRS conditions into those in which virtual management differs from direct in-person visits and conditions in which treatment would emphasize behavioral and conservative counseling but not deviate from current management paradigms. We conducted expedited literature review on four topics (telemedicine in FPMRS, pessary management, urinary tract infections, urinary retention) and addressed four other topics (urinary incontinence, prolapse, fecal incontinence, defecatory dysfunction) based on existing systematic reviews and guidelines. We further compiled expert consensus regarding management of FPMRS patients in the virtual setting, scenarios when in-person visits are necessary, symptoms that should alert providers, and specific considerations for FPMRS patients with suspected or confirmed COVID-19.

          Results

          Behavioral, medical, and conservative management will be valuable as first-line virtual treatments. Certain situations will require different treatments in the virtual setting while others will require an in-person visit despite the risks of COVID-19 transmission.

          Conclusions

          We have presented guidance for treating FPMRS conditions via telemedicine based on rapid literature review and expert consensus and presented it in a format that can be actively referenced.

          Related collections

          Most cited references111

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

          Summary Background In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia. Methods In this retrospective, single-centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020. Cases were confirmed by real-time RT-PCR and were analysed for epidemiological, demographic, clinical, and radiological features and laboratory data. Outcomes were followed up until Jan 25, 2020. Findings Of the 99 patients with 2019-nCoV pneumonia, 49 (49%) had a history of exposure to the Huanan seafood market. The average age of the patients was 55·5 years (SD 13·1), including 67 men and 32 women. 2019-nCoV was detected in all patients by real-time RT-PCR. 50 (51%) patients had chronic diseases. Patients had clinical manifestations of fever (82 [83%] patients), cough (81 [82%] patients), shortness of breath (31 [31%] patients), muscle ache (11 [11%] patients), confusion (nine [9%] patients), headache (eight [8%] patients), sore throat (five [5%] patients), rhinorrhoea (four [4%] patients), chest pain (two [2%] patients), diarrhoea (two [2%] patients), and nausea and vomiting (one [1%] patient). According to imaging examination, 74 (75%) patients showed bilateral pneumonia, 14 (14%) patients showed multiple mottling and ground-glass opacity, and one (1%) patient had pneumothorax. 17 (17%) patients developed acute respiratory distress syndrome and, among them, 11 (11%) patients worsened in a short period of time and died of multiple organ failure. Interpretation The 2019-nCoV infection was of clustering onset, is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as acute respiratory distress syndrome. In general, characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia. Further investigation is needed to explore the applicability of the MuLBSTA score in predicting the risk of mortality in 2019-nCoV infection. Funding National Key R&D Program of China.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.

            Guidelines for the diagnosis, prevention, and management of persons with catheter-associated urinary tract infection (CA-UTI), both symptomatic and asymptomatic, were prepared by an Expert Panel of the Infectious Diseases Society of America. The evidence-based guidelines encompass diagnostic criteria, strategies to reduce the risk of CA-UTIs, strategies that have not been found to reduce the incidence of urinary infections, and management strategies for patients with catheter-associated asymptomatic bacteriuria or symptomatic urinary tract infection. These guidelines are intended for use by physicians in all medical specialties who perform direct patient care, with an emphasis on the care of patients in hospitals and long-term care facilities.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial.

              To test whether D-mannose powder is effective for recurrent urinary tract infection (UTI) prevention.
                Bookmark

                Author and article information

                Contributors
                caragrimesmd@gmail.com
                Journal
                Int Urogynecol J
                Int Urogynecol J
                International Urogynecology Journal
                Springer International Publishing (Cham )
                0937-3462
                1433-3023
                27 April 2020
                : 1-27
                Affiliations
                [1 ]GRID grid.260917.b, ISNI 0000 0001 0728 151X, Departments of Obstetrics and Gynecology and Urology, , New York Medical College, ; 19 Bradhurst Avenue, Suite 2700 South Hawthorne, Valhalla, NY 10532 USA
                [2 ]GRID grid.40263.33, ISNI 0000 0004 1936 9094, Center for Evidence Synthesis in Health, Brown School of Public Health, , Brown University, ; Providence, RI USA
                [3 ]GRID grid.418302.c, ISNI 0000 0004 0389 7490, Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, , TriHealth, ; Cincinnati, OH USA
                [4 ]GRID grid.63368.38, ISNI 0000 0004 0445 0041, Department of Obstetrics and Gynecology, Division of Urogynecology, , Houston Methodist Hospital, ; Houston, TX USA
                [5 ]GRID grid.265008.9, ISNI 0000 0001 2166 5843, Department of Obstetrics and Gynecology, , Sidney Kimmel Medical College of Thomas Jefferson University, ; Philadelphia, PA USA
                [6 ]GRID grid.89336.37, ISNI 0000 0004 1936 9924, Department of Women’s Health, Dell Medical School, , University of Texas Austin, ; Austin, TX USA
                [7 ]GRID grid.266832.b, ISNI 0000 0001 2188 8502, Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, , University of New Mexico, ; Albuquerque, NM USA
                [8 ]GRID grid.15276.37, ISNI 0000 0004 1936 8091, Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, , University of Florida, ; Gainesville, FL USA
                [9 ]GRID grid.430725.7, ISNI 0000 0004 0398 034X, Department of Women’s Health, Female Pelvic Medicine and Reconstructive Surgery, , St. Elizabeth Healthcare, ; Fort Thomas, KY USA
                [10 ]GRID grid.22072.35, ISNI 0000 0004 1936 7697, Section of Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, , University of Calgary, ; Calgary, Alberta Canada
                [11 ]GRID grid.213910.8, ISNI 0000 0001 1955 1644, Department of Obstetrics and Gynecology, , Georgetown University School of Medicine, ; Washington, DC USA
                [12 ]GRID grid.10698.36, ISNI 0000000122483208, Division of Urogynecology and Reconstructive Pelvic Surgery, Department of Obstetrics and Gynecology, , University of North Carolina at Chapel Hill, ; Chapel Hill, NC USA
                [13 ]GRID grid.21729.3f, ISNI 0000000419368729, Department of Obstetrics and Gynecology, , Columbia University Irving Medical Center, ; New York, NY USA
                Article
                4314
                10.1007/s00192-020-04314-4
                7185267
                32342112
                c081ac2e-3f78-4408-9e17-1e531abee818
                © The International Urogynecological Association 2020

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 6 April 2020
                : 7 April 2020
                Funding
                Funded by: Society for Gynecologic surgeons
                Award ID: Funding provided by the Society of Gynecologic Surgeons (SGS) supports assistance by methods experts in systematic reviews and other logistics.
                Categories
                Original Article

                Obstetrics & Gynecology
                covid-19,urogynecology,fpmrs,telemedicine,systematic review,pandemic,virtual visit
                Obstetrics & Gynecology
                covid-19, urogynecology, fpmrs, telemedicine, systematic review, pandemic, virtual visit

                Comments

                Comment on this article